[go: up one dir, main page]

BRPI0506764A - microemulsões para composições farmacêuticas - Google Patents

microemulsões para composições farmacêuticas

Info

Publication number
BRPI0506764A
BRPI0506764A BRPI0506764-2A BRPI0506764A BRPI0506764A BR PI0506764 A BRPI0506764 A BR PI0506764A BR PI0506764 A BRPI0506764 A BR PI0506764A BR PI0506764 A BRPI0506764 A BR PI0506764A
Authority
BR
Brazil
Prior art keywords
microemulsions
pharmaceutical compositions
compositions
pharmaceutical
adrm
Prior art date
Application number
BRPI0506764-2A
Other languages
English (en)
Inventor
Kristine M Brophy
Jeffery J Seyer
Peter Ramsey
Christopher Roper
Andrew Durber
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BRPI0506764A publication Critical patent/BRPI0506764A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

MICROEMULSõES PARA COMPOSIçõES FARMACêUTICAS A presente invenção refere-se a composições farmacêuticas em microemulsão que compreendem ingredientes ativos farmacêuticos que são hodrótropos que facilitam a formação de microemulsões. A invensão também fornece métodos de obtenção das composições e a utilização das composições em cápsulas de casca mole com recheio líquido inclusive cápsulas que têm cascas de materiais derivados sem ser de animais (por exemplo, não-ADRM).
BRPI0506764-2A 2004-01-09 2005-01-06 microemulsões para composições farmacêuticas BRPI0506764A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53558104P 2004-01-09 2004-01-09
PCT/US2005/000172 WO2005070399A1 (en) 2004-01-09 2005-01-06 Microemulsions for pharmaceutical compositions

Publications (1)

Publication Number Publication Date
BRPI0506764A true BRPI0506764A (pt) 2007-05-22

Family

ID=34806948

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0506764-2A BRPI0506764A (pt) 2004-01-09 2005-01-06 microemulsões para composições farmacêuticas

Country Status (8)

Country Link
US (2) US20050152968A1 (pt)
EP (1) EP1701710A1 (pt)
JP (1) JP2007517884A (pt)
CN (1) CN1909891A (pt)
AU (1) AU2005206084A1 (pt)
BR (1) BRPI0506764A (pt)
CA (1) CA2552611A1 (pt)
WO (1) WO2005070399A1 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2560298A1 (en) * 2004-03-24 2005-09-29 Takeda Pharmaceutical Company Limited Preparation with elevated content
EP1951208A2 (en) * 2005-10-26 2008-08-06 Banner Pharmacaps Inc. Lipophilic vehicle-based dual controlled release matrix system as capsule fill
WO2007050975A2 (en) * 2005-10-26 2007-05-03 Banner Pharmacaps, Inc. Hydrophilic vehicle-based dual controlled release matrix system as capsule fill
BRPI0713054A2 (pt) * 2006-06-30 2012-04-17 Mcneil Ppc Inc cápsulas sólidas enchidas com lìquido contendo ibuprofeno
GB0818473D0 (en) 2008-10-08 2008-11-12 Probio Nutraceuticals As Composition
GB2477590A (en) * 2010-02-05 2011-08-10 Biocopea Ltd A non-steroidal anti-inflammatory drug (NSAID) formulation comprising a lipid carrier
CN101889963B (zh) * 2010-08-05 2011-09-28 上海媚兰生物科技发展有限公司 一种微乳液组合物及其制备方法
US9308213B2 (en) 2010-10-29 2016-04-12 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US11202831B2 (en) 2010-10-29 2021-12-21 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US9737500B2 (en) 2010-10-29 2017-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US10695432B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US8895537B2 (en) 2010-10-29 2014-11-25 Infirst Healthcare Ltd. Compositions and methods for treating cardiovascular diseases
US10695431B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US9271950B2 (en) 2010-10-29 2016-03-01 Infirst Healthcare Limited Compositions for treating chronic inflammation and inflammatory diseases
US9744132B2 (en) 2010-10-29 2017-08-29 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US11730709B2 (en) 2010-10-29 2023-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US9504664B2 (en) 2010-10-29 2016-11-29 Infirst Healthcare Limited Compositions and methods for treating severe pain
US11224659B2 (en) 2010-10-29 2022-01-18 Infirst Healthcare Limited Solid solution compositions and use in severe pain
JP5769760B2 (ja) * 2013-06-25 2015-08-26 アール．ピー． シェーラー テクノロジーズ エルエルシー ソフトカプセル用シェル形成組成物及びソフトカプセル
AU2016361585A1 (en) * 2015-11-23 2018-07-12 Undoo, LLC Composition of olivetol and method of use reduce or inhibit the effects of tetrahydrocannabinol in the human body
WO2020074361A1 (en) * 2018-10-08 2020-04-16 Chanelle Pharmaceuticals Manufacturing Ltd. A soft-gel capsule formulation, method of manufacture and use thereof

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems
US4918103A (en) * 1988-07-25 1990-04-17 Formulations Development Labs Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs
US5059626A (en) * 1988-07-25 1991-10-22 Applied Analytical Industries, Inc. Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
JP3121080B2 (ja) * 1991-12-19 2000-12-25 アール・ピー・シーラー コーポレイション カプセル封入用溶液
US5376688A (en) * 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
US5342626A (en) * 1993-04-27 1994-08-30 Merck & Co., Inc. Composition and process for gelatin-free soft capsules
DE4440337A1 (de) * 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
US5468502A (en) * 1994-12-20 1995-11-21 American Home Products Corporation Ibuprofen enhancing solvent system
US6221391B1 (en) * 1998-11-23 2001-04-24 Accucaps Industries Limited Self-emulsifying ibuprofen solution and soft gelatin capsule for use therewith
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6761903B2 (en) * 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US6309663B1 (en) * 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
US6458383B2 (en) * 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
DE59908424D1 (de) * 1999-07-02 2004-03-04 Cognis Iberia Sl Mikrokapseln - I
US6623765B1 (en) * 2000-08-01 2003-09-23 University Of Florida, Research Foundation, Incorporated Microemulsion and micelle systems for solubilizing drugs
AU2001280124A1 (en) * 2000-08-25 2002-03-04 Kowa Company Ltd. Ibuprofen solutions for capsule-filling and capsule prepartions
US6387400B1 (en) * 2000-08-29 2002-05-14 R.P. Scherer Technologies, Inc. Process for preparing pharmaceutical compositions for use with soft gelatin formulations
EP1344523A1 (en) * 2002-03-11 2003-09-17 Warner-Lambert Company Ibuprofen solution for hard gelatin capsules
US6689382B2 (en) * 2002-05-15 2004-02-10 Procaps S.A. Soft shell gelatin capsules containing non-steroidal anti-inflammatories
US20030232097A1 (en) * 2002-06-17 2003-12-18 Strides Inc. Oily wax matrix suspension formulation comprising ibuprofen free acid and potassium salt of ibuprofen

Also Published As

Publication number Publication date
EP1701710A1 (en) 2006-09-20
WO2005070399A1 (en) 2005-08-04
CN1909891A (zh) 2007-02-07
US20050152968A1 (en) 2005-07-14
AU2005206084A1 (en) 2005-08-04
JP2007517884A (ja) 2007-07-05
CA2552611A1 (en) 2005-08-04
US20090155353A1 (en) 2009-06-18

Similar Documents

Publication Publication Date Title
BRPI0506764A (pt) microemulsões para composições farmacêuticas
EA200601727A1 (ru) Улучшенные пуллулановые капсулы
MX2010006199A (es) Composicion nutricional enterica liquida basada en caseina micelar, densa en cuanto a proteina.
BRPI0409133A (pt) formulações farmacêuticas contendo metilnaltrexona
CY1114769T1 (el) Διασπαρσιμα στο νερο αγροχημικα σκευασματα που αποτελουνται απο πολυαλκοξυτριγλυκεριδια ως υποκινητες διεισδυσης
BRPI0515994A (pt) biossìntese de floroglucinol e preparo de 1, 3-dihidróxibenzeno a partir do mesmo
MA31231B1 (fr) Anticorps anti-robo4 et utilisations de ceux-ci
UA99659C2 (uk) Мультивалентна вакцина з нативних везикул зовнішньої мембрани менінгококів, способи її застосування
BRPI0709847B8 (pt) composição farmacêutica sólida de liberação rápida contendo paracetamol e carbonato de cálcio
BRPI0414722A (pt) meios sem produto animal e processos para obtenção de uma toxina botulìnica
MX2010005589A (es) Composicion para el cuidado personal.
CY1110157T1 (el) Χιμαιρικα ανασυνδυασμενα αντιγονα του toxoplasma gondii
TW200501965A (en) Highly pure fondaparinux sodium composition,process for preparing said composition and pharmaceutical compositions containing it as active principle
CY1107681T1 (el) Χρηση παραγωγων τροπινεστερα για την παραγωγη φαρμακευτικων μεσων
BRPI0407181A (pt) Formulação farmacêutica
BR0212807A (pt) Processo para a preparação de formas de dosagem de dissolução rápida
EA200970449A1 (ru) Композиции ацетаминофена, обладающие сведенными к минимуму побочными эффектами, включая пониженную гепатотоксичность
NO20072290L (no) Organiske forbindelser.
ECSP045493A (es) Nuevas composiciones farmacéuticas que contienen flibanserina polimorfo a
BRPI0408895A (pt) formulações de cladribina para administração oral e transmucosal aperfeiçoada
AR061093A1 (es) Composiciones de calcio
TW200726479A (en) Method of inducing neutralizing antibodies to human immunodeficiency virus
JP2006512078A5 (pt)
WO2007053424A3 (en) Silicone vesicles containing actives
PE20110119A1 (es) Asociacion entre ferroquina y artesunato para el tratamiento del paludismo

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]